| Serial Number | 98254371 |
| Word Mark | DELVE |
| Filing Date | Friday, November 3, 2023 |
| Status | 654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED |
| Status Date | Sunday, August 24, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, genetic and genomic diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases; therapeutic pharmaceuticals for the treatment and prevention of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, genetic and genomic diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases |
| Goods and Services | Medical research and development; research and development in the field of computational biology, bioinformatics, genetics, genomics, biotechnology, pharmaceuticals, and therapeutics; platform as a service (PaaS) featuring computer software platforms for drug discovery; pharmaceutical and biopharmaceutical research and development; drug development services, namely, pharmaceutical drug development services; development of pharmaceuticals and therapeutic agents for others, namely, development of pharmaceutical preparations and medicines; platform as a service (PaaS) featuring computer software platforms for enabling research and development of pharmaceutical data in the field of computational biology, bioinformatics, genetics, genomics, biotechnology and pharmaceuticals; DNA, RNA, and genomic analysis and sequencing services for medical research purposes; none of the foregoing relating to finding people scientific studies to participate in or recruiting participants for scientific studies |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 27, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 26, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | PROLOGUE MEDICINES, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CAMBRIDGE, MA 02142 |
| Party Name | Flagship Labs 89, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Monday, November 27, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, December 6, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Friday, January 19, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, January 24, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 24, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 24, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, January 26, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, January 26, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 26, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 4, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, March 4, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, March 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 27, 2024 | LETTER OF SUSPENSION E-MAILED |
| Thursday, June 27, 2024 | SUSPENSION LETTER WRITTEN |
| Thursday, June 27, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, June 3, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 3, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 4, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 6, 2025 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Sunday, August 10, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Sunday, August 24, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |